In the Media

Lawrence A. Tabak, who is currently performing the duties of the NIH Director, spotlights a new study by Prof. James Collins and his colleagues aimed at exploring the potential of AI to streamline the process of selecting new antibiotics. “In future studies, the Collins lab will continue to incorporate and train the computers on even more biochemical and biophysical data to help with the predictive process," Tabak writes. "That’s why this study should be interpreted as an interim progress report on an area of science that will only get better with time.”